UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)

Breast (Edinburgh), 2020-12, Vol.54, p.286-292

2020

Volltextzugriff (PDF)

354 Lenvatinib and pembrolizumab in advanced endometrial carcinoma (EC): long-term efficacy and safety update from a phase 1b/2 study

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A381-A381

2021

Volltextzugriff (PDF)

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Journal of clinical oncology, 2020-09, Vol.38 (26), p.2981-2992

2020

Volltextzugriff (PDF)

Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer

Gynecologic oncology, 2020-05, Vol.157 (2), p.379-385

2020

Volltextzugriff (PDF)

A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update

Journal of clinical oncology, 2023-02, Vol.41 (5), p.974-979

2023

Volltextzugriff (PDF)

Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-resistant ovarian cancer: Final findings from the FORWARD II study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.5520-5520

2019

Volltextzugriff (PDF)

Lenvatinib (LEN) plus pembrolizumab (PEMBRO) for early-line treatment of advanced/recurrent endometrial cancer (EC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6083-6083

2020

Volltextzugriff (PDF)

Abstract GS2-06: Primary results of SOLTI-1402/CORALLEEN phase 2 trial of neoadjuvant ribociclib plus letrozole versus chemotherapy in PAM50 Luminal B early breast cancer: An open-label, multicenter, two-arm, randomized study

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.GS2-06-GS2-06

2020

Volltextzugriff (PDF)

First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future Directions

Drugs (New York, N.Y.), 2014-06, Vol.74 (8), p.879-889

2014

Volltextzugriff (PDF)

Tratamiento multimodal en cáncer de cérvix metastásico con respuesta favorable

Progresos de obstetricia y ginecología, 2015-11, Vol.58 (9), p.417-421

2015

Volltextzugriff (PDF)

Bevacizumab as front-line treatment for newly diagnosed epithelial cancer

Expert review of anticancer therapy, 2013-02, Vol.13 (2), p.123-129

2013

Volltextzugriff (PDF)

Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: Results of the CNIO-BR002 phase I-trial

Molecular oncology, 2014-12, Vol.8 (8), p.1719-1728

2014

Volltextzugriff (PDF)

Will the carboplatin-paclitaxel-bevacizumab combination become the preferred option as the first line in advanced cervical cancer? A small experience from a single oncologic Center

Cancer Breaking News, 2017-04, Vol.5 (1), p.21-24

2017

Volltextzugriff (PDF)

First national survey of the diagnosis of Helicobacter pylori infection in Clinical Microbiology Laboratories in Spain

Enfermedades infecciosas y microbiologia clinica (English ed.), 2020-11, Vol.38 (9), p.410-416

2020

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(16)

Sprache

Englisch
(15)
Spanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination

Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)

354 Lenvatinib and pembrolizumab in advanced endometrial carcinoma (EC): long-term efficacy and safety update from a phase 1b/2 study

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer

Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial

A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update

Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-resistant ovarian cancer: Final findings from the FORWARD II study

Lenvatinib (LEN) plus pembrolizumab (PEMBRO) for early-line treatment of advanced/recurrent endometrial cancer (EC)

Abstract GS2-06: Primary results of SOLTI-1402/CORALLEEN phase 2 trial of neoadjuvant ribociclib plus letrozole versus chemotherapy in PAM50 Luminal B early breast cancer: An open-label, multicenter, two-arm, randomized study

First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future Directions

Tratamiento multimodal en cáncer de cérvix metastásico con respuesta favorable

Bevacizumab as front-line treatment for newly diagnosed epithelial cancer

Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: Results of the CNIO-BR002 phase I-trial

Will the carboplatin-paclitaxel-bevacizumab combination become the preferred option as the first line in advanced cervical cancer? A small experience from a single oncologic Center

First national survey of the diagnosis of Helicobacter pylori infection in Clinical Microbiology Laboratories in Spain

Suchergebnisse filtern